Biosolution Co.Ltd (086820) — Cash Flow Reinvestment Rate
Biosolution Co.Ltd (086820) has a Cash Flow Reinvestment Rate of 2.23x as of September 2025, reinvesting ₩38.75 Million (capex ₩22.15 Million plus investments ₩16.60 Million) from operating cash flow of ₩17.41 Million. Explore 086820 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Biosolution Co.Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for Biosolution Co.Ltd across 3 annual periods. Also explore Biosolution Co.Ltd (086820) total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Biosolution Co.Ltd (2018–2023)
Year-by-year capital reinvestment analysis for Biosolution Co.Ltd. For live market cap and broader valuation context, see Biosolution Co.Ltd stock valuation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 5.02x | ₩10.85 Billion | ₩2.16 Billion | ₩1.16 Billion | ▼ -97.7% |
| 2021 | 214.45x | ₩17.86 Billion | ₩83.29 Million | ₩663.15 Million | ▲ +411.1% |
| 2018 | 41.96x | ₩43.06 Billion | ₩1.03 Billion | ₩707.50 Million | — |